Accent Capital Management’s GSK GSK Stock Holding History

Accent Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43.1K	Buy	+781	New	+$42.3K	0.02%	114
2025 Q3	–	Sell	-120	Closed	-$4.66K	–	397
2025 Q2	$4.66K	Hold	120	–	–	﹤0.01%	337
2025 Q1	$5.02K	Sell	120 -800	-87%	-$29.3K	﹤0.01%	255
2024 Q4	$31.5K	Hold	920	–	–	0.02%	93
2024 Q3	$38K	Hold	920	–	–	0.02%	106
2024 Q2	$35.4K	Hold	920	–	–	0.02%	108
2024 Q1	$39.8K	Hold	920	–	–	0.03%	86
2023 Q4	$34.1K	Buy	+920	New	+$33K	0.03%	117

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Accent Capital Management's GSK Position: Q1 2026 in Review

Accent Capital Management opened a new position in GSK (GSK) in Q1 2026: 781 shares worth $43.1K. The stake represents 0.02% of the portfolio and ranks #114 among its holdings. This is a return to the name: Accent Capital Management previously reported a position in GSK as recently as Q2 2025.

Accent Capital Management first reported a position in GSK in Q4 2023 and has held it in 8 quarters since. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Accent Capital Management held 781 shares of GSK worth $43.1K as of Q1 2026.
GSK was a new Accent Capital Management position in Q1 2026.
GSK made up 0.02% of Accent Capital Management's portfolio in Q1 2026, its #114 holding.
Accent Capital Management first reported a position in GSK in Q4 2023 and has held it in 8 quarters since.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Accent Capital Management's 13F filing for Q1 2026, filed 11 May 2026.